KMID : 0900220210280020073
|
|
´ëÇѺñ°úÇÐȸÁö 2021 Volume.28 No. 2 p.73 ~ p.80
|
|
Contemporary Review of Olfactory Dysfunction in COVID-19
|
|
Jung Hwae-Joon
Lee Heung-Man
|
|
Abstract
|
|
|
The pandemic of coronavirus disease 2019 (COVID-19) is an extreme threat to international health care, resulting in more than two million deaths. Data reveal that olfactory disorder is a characteristic symptom of COVID-19 and has unique clinical manifestations. The olfactory dysfunction induced by COVID-19 has sudden onset, short duration, and rapid recovery, with anosmia often the only symptom. Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) affects the human body by binding to angiotensin converting enzyme 2 (ACE2) of the olfactory epithelium. However, the etiology of COVID-19-induced olfactory dysfunction is unclear. In many countries, vaccines for COVID-19 in human are beginning to be administered. Conventional conservative treatments are common for olfactory disorders caused by COVID-19. Rhinologists should be aware of olfactory dysfunction to avoid delayed diagnosis of COVID-19. The article reviews the latest scientific evidence of anosmia in COVID-19.
|
|
KEYWORD
|
|
Olfaction disorders, COVID-19, Coronavirus, Physiopathology, Etiology
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|